Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide to accelerate consolidation of regenerated bone after tibial distraction osteogenesis
2008-000592-24Phase 3Active
- Sponsor
- BG Kliniken
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of teriparatide in osteomyelitis (OM) (2 arms), sponsored by BG Kliniken. Primary endpoint: Bone mineral density of regenerated bone. Started May 2008; status: active.
02
Drugs
teriparatide
03
Conditions
osteomyelitis (OM)
Beyond the preview
Go deeper on 2008-000592-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000592-24.